Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Apply
Ivonescimab & Carbo-Docetaxel
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step